LncRNA BCAR4 expression predicts the clinical response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

BACKGROUND: Neoadjuvant chemotherapy (NAC) is an important treatment for locally advanced breast cancer (LABC). However, there are no effective biomarkers to predict the efficacy. Therefore, there is an urgent need for new biomarkers to predict the response of LABC to NAC. LncRNA BCAR4 has been dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Feng-Jiao, Li, Yi, Xu, Meng-Xi, Zhou, Tie, Wu, Shun, Hu, Kang, Li, Yan, Sun, Su-Hong, Luo, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673519/
https://www.ncbi.nlm.nih.gov/pubmed/34151842
http://dx.doi.org/10.3233/CBM-210048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673519/
https://www.ncbi.nlm.nih.gov/pubmed/34151842
http://dx.doi.org/10.3233/CBM-210048

Ejemplares similares